stockrow
Friday 6 November 2026
Export HTFL’s income statement to Excel — free account
Heartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.
- Revenue
- +47.6%
- EPS
- +87.7%
- Free cash flow
- +62.6%
Quarter to June 2026, against a year earlier
52.48
0.53
+1.02%
Follow HTFL
Alert me
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
Piotroski F-Score |
5 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 |
Altman Z-Score |
7.22 | — | — |
P/S ratio |
6.10 | 1.22 | 1.22 |
Altman Z″-Score (non-manufacturers) |
(2.45) | (27.90) | (14.00) |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
Beneish M-Score |
(2.55) | (3.30) | — |
P/Operating CF |
(101.39) | (6.65) | (6.65) |
P/B ratio |
3.57 | 0.00 | 0.00 |
Price to Tangible BV |
3.57 | 0.00 | 0.00 |
EV/Sales |
6.13 | 1.91 | 1.91 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
(19.99) | (4.38) | (4.38) |
EV/FCF |
(18.29) | (4.17) | (4.17) |
Quick Ratio |
4.87 | 2.27 | 4.37 |
Current Ratio |
5.20 | 2.45 | 4.52 |
Net Debt/EBITDA |
3.41 | (1.65) | (0.18) |
Debt/Assets |
0.00% | 114.93% | 72.42% |
Debt/Equity |
0.00 | (1.50) | (14.89) |
Asset Turnover |
0.74 | 0.83 | 0.00 |
Operating CF/Net income |
0.46 | 0.72 | 0.62 |
Capex/Depreciation |
(0.41) | (0.45) | (0.59) |
Interest Coverage |
(4.22) | (2.69) | (2.95) |
| 41.80% | 11.78% | 0.00% | |
| (48.85%) | (63.49%) | 0.00% | |
ROIC |
(32.33%) | 0.00% | (2,031.71%) |
Return on Tangible Assets |
(62.65%) | (167.40%) | (98.51%) |
Average Days of Receivables |
60.84 | 71.48 | 86.03 |
Research and Development Expense of Revenue |
36.88% | 34.59% | 41.13% |
Selling, General and Administrative Expense of Revenue |
76.32% | 89.15% | 109.10% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
7.93% | 8.12% | 13.62% |
Graham Net Nets |
0.15 | (0.92) | (0.92) |
Graham Number |
0.00 | 254.60 | 0.00 |
Earnings Yield |
(27.57%) | (54.94%) | (54.94%) |
Free Cash Flow Yield |
(5.50%) | (37.46%) | (37.46%) |
Revenue per Share |
4.78 | 23.46 | 17.84 |
Operating CF per Share |
(1.47) | (12.87) | (15.65) |
Capex per Share |
(0.14) | (0.81) | (1.25) |
Free Cash Flow per Share |
(1.60) | (13.68) | (16.90) |
Cash per Share |
4.80 | 9.61 | 25.13 |
Shareholders Equity per Share |
8.16 | (16.95) | (1.84) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
8.16 | (16.95) | (1.84) |
Free Cash Flow |
(59.05) | (73.36) | (82.54) |
Working Capital |
177.83 | 48.68 | 115.63 |
Capital Expenditures |
(5.02) | (4.36) | (6.10) |
Net Current Asset Value |
161.40 | (127.33) | (45.60) |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.03 | 0.07 |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
1.43 | 1.09 | 1.05 |
Cash ROIC |
(12.37%) | (75.60%) | (33.31%) |
Accounts Receivable Turnover |
6.52 | 5.57 | 0.00 |
Accounts Payable Turnover |
13.52 | 10.89 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 |
Average Days of Payables |
28.32 | 33.41 | 36.18 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 |
Average Receivables |
26.99 | 22.59 | — |
Average Payables |
3.02 | 2.88 | — |
Average Assets |
239.08 | 151.88 | — |
Average Common Equity |
(279.42) | (818.52) | — |
Columns are period end dates · fundamentals updated 25 Oct 2026